Treprostinil Investment Portfolios

Liquidia Corporation Expands Partnership with Pharmosa Biopharm to Advance Inhaled Treprostinil Therapy Oct 3, 2024

Court Rules Against United Therapeutics, Awards Over $137 Million to Liquidia Corp for Generic Drug Launch Delays Sep 16, 2024